ZANAMIVIR Side Effects

7020961-4 | Bradycardia
on Jan 12, 2010 Female patient from UNITED STATES , 32 years of age, was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with INTUBATION (View Intubation Review and Intubation Label ).

6981000-4 | Acidosis, Aspergillosis, Diffuse Alveolar Damage, Haemodynamic Instability, Hypoxia, Ileus Paralytic, Pneumonitis, Renal Failure
Patient was taking Zanamivir (View Usage). Patient had the following side effects: acidosis, aspergillosis, diffuse alveolar damage, haemodynamic instability, hypoxia, ileus paralytic, pneumonitis, renal failure on Sep 03, 2010 from NETHERLANDS Additional patient health information: Male patient , 58 years of age, . Zanamivir dosage: . During the same period patient was treated with OSELTAMIVIR (75mg Twice Per Day) (View Oseltamivir Review and Oseltamivir Label ). Patient was hospitalized.

6934074-0 | Live Birth
Adverse event was reported on Aug 06, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: ) was diagnosed with influenza and. Location: JAPAN , 19 years of age, After Zanamivir was administered, patient had the following side effects: live birth. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ).

6912264-0 | Live Birth
on Jul 26, 2010 Female patient from JAPAN , 19 years of age, was diagnosed with influenza and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: live birth. Zanamivir dosage: . During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ).


6849150-0 | Live Birth
on Jul 07, 2010 Female patient from UNITED STATES , 25 years of age, was diagnosed with influenza and was treated with Zanamivir (View Usage). Patient had the following side effects: live birth. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with TAMIFLU (View Tamiflu Review and Tamiflu Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TYLENOL (View Tylenol Review and Tylenol Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), LACTATED RINGER'S (View Lactated Ringer's Review and Lactated Ringer's Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6827761-6 | Live Birth
Patient was taking Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: live birth on Jul 07, 2010 from UNITED STATES Additional patient health information: Female patient , 25 years of age, was diagnosed with influenza and. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with TAMIFLU (View Tamiflu Review and Tamiflu Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TYLENOL (View Tylenol Review and Tylenol Label ), AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), LACTATED RINGER'S (View Lactated Ringer's Review and Lactated Ringer's Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6754034-2 | Cytolytic Hepatitis
Adverse event was reported on May 26, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: 600mg Twice Per Day) was diagnosed with influenza, bronchospasm, sedation, nausea (What is nausea?) and. Location: FRANCE , weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (20mg Three Times Per Day) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE MAGNESIUM (40mg Per Day) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), TERBUTALINE SULFATE (5mg Three Times Per Day) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), LORAZEPAM (.5mg Three Times Per Day) (View Lorazepam Review and Lorazepam Label ), INSULINE (10iu Twice Per Day) (View Insuline Review and Insuline Label ), METOCLOPRAMIDE (10mg Three Times Per Day) (View Metoclopramide Review and Metoclopramide Label ).

6740222-8 | Acute Respiratory Distress Syndrome, Cytolytic Hepatitis, Epistaxis, Haemodynamic Instability, Haemolysis, Melaena, Multi-organ Failure, Shock Haemorrhagic
on May 10, 2010 Female patient from FRANCE , weighting 176.4 lb, was diagnosed with h1n1 influenza, acute respiratory distress syndrome, herpes virus infection, pulmonary fibrosis (What is pulmonary fibrosis?) and was treated with Zanamivir (View Usage). Patient had the following side effects: acute respiratory distress syndrome, cytolytic hepatitis, epistaxis, haemodynamic instability, haemolysis, melaena, multi-organ failure, shock haemorrhagic. Zanamivir dosage: 400mg Twice Per Day. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), TAHOR (View Tahor Review and Tahor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VENTILATION (View Ventilation Review and Ventilation Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), CORTICOSTEROID (View Corticosteroid Review and Corticosteroid Label ).

6726408-7 | Cytolytic Hepatitis
on May 06, 2010 Male patient from FRANCE , weighting 205.0 lb, was diagnosed with influenza, asthma (What is asthma?) and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cytolytic hepatitis. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with CEFTRIAXONE (1g Per Day) (View Ceftriaxone Review and Ceftriaxone Label ), SPIRAMYCIN (1.5iu6 Three Times Per Day) (View Spiramycin Review and Spiramycin Label ), TERBUTALIN (5mg Four Times Per Day) (View Terbutalin Review and Terbutalin Label ), METHYLPREDNISOLONE 4MG TAB (80mg Per Day) (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ).

6700576-5 | Ventricular Tachycardia
Patient was taking Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular tachycardia on Apr 19, 2010 from SPAIN Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with influenza and. Zanamivir dosage: 600mg Twice Per Day.

6692475-2 | Rash Morbilliform, Renal Failure Acute
Adverse event was reported on Apr 19, 2010 by a Male patient taking Zanamivir (View Usage) (Dosage: ) was diagnosed with h1n1 influenza, pneumonia (What is pneumonia?), prophylaxis and. Location: CANADA , weighting 198.4 lb, Patient had the following side effects: rash morbilliform, renal failure acute. During the same period patient was treated with CEFTRIAXONE (2g Per Day) (View Ceftriaxone Review and Ceftriaxone Label ), MOXIFLOXACIN HCL (400mg Per Day) (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), RANITIDINE (150mg Twice Per Day) (View Ranitidine Review and Ranitidine Label ), FUROSEMIDE (40mg Twice Per Day) (View Furosemide Review and Furosemide Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ).

6690611-5 | Cardiac Arrest, Torsade De Pointes, Ventricular Arrhythmia
on Apr 12, 2010 Female patient from FRANCE , weighting 198.4 lb, was diagnosed with influenza, anxiety (What is anxiety?) and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), torsade de pointes, ventricular arrhythmia. Zanamivir dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6685105-7 | Arrhythmia
on Apr 07, 2010 Male patient from SPAIN , weighting 176.4 lb, was diagnosed with influenza and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?). Zanamivir dosage: 600mg Twice Per Day.

6685102-1 | Cytolytic Hepatitis
Patient was taking Zanamivir (View Usage). Patient had the following side effects: cytolytic hepatitis on Apr 06, 2010 from FRANCE Additional patient health information: Female patient , weighting 142.2 lb, was diagnosed with influenza, pneumonia (What is pneumonia?), sedation, paralysis (What is paralysis?), thrombosis prophylaxis, constipation (What is constipation?) and. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with CEFTRIAXONE (1g Per Day) (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CISATRACURIUM BESYLATE (View Cisatracurium Besylate Review and Cisatracurium Besylate Label ), ENOXAPARIN SODIUM (4000iu Per Day) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), MACROGOL (2 Per Day) (View Macrogol Review and Macrogol Label ).

6673032-0 | Arrhythmia
Adverse event was reported on Mar 29, 2010 by a Male patient taking Zanamivir (View Usage) (Dosage: 600mg Twice Per Day) was diagnosed with influenza and. Location: SPAIN , weighting 176.4 lb, After Zanamivir was administered, patient had the following side effects: arrhythmia (What is arrhythmia?).

6667665-5 |
on Mar 31, 2010 Male patient from GERMANY , weighting 264.6 lb, was diagnosed with h1n1 influenza, sepsis (What is sepsis?) and was treated with Zanamivir (View Usage). . Zanamivir dosage: . During the same period patient was treated with LINEZOLID (600mg Three Times Per Day) (View Linezolid Review and Linezolid Label ), IMIPENEM (.5g Four Times Per Day) (View Imipenem Review and Imipenem Label ), VORICONAZOLE (400mg Twice Per Day) (View Voriconazole Review and Voriconazole Label ).

6647292-6 | Agitation, Anuria, Anxiety, Ascites, Cardiogenic Shock, Circulatory Collapse, Gastrointestinal Haemorrhage, Haemodynamic Instability, Haemorrhagic Stroke
on Mar 12, 2010 Female patient from FRANCE , weighting 156.5 lb, was diagnosed with h1n1 influenza, myocarditis, respiratory distress and was treated with Zanamivir (View Usage). Patient had the following side effects: agitation, anuria, anxiety (What is anxiety?), ascites, cardiogenic shock, circulatory collapse, gastrointestinal haemorrhage, haemodynamic instability, haemorrhagic stroke. Zanamivir dosage: 250mg Twice Per Day. During the same period patient was treated with TAREG (40mg Per Day) (View Tareg Review and Tareg Label ), TAMIFLU (150mg Twice Per Day) (View Tamiflu Review and Tamiflu Label ), CORTICOID (1mgk Per Day) (View Corticoid Review and Corticoid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), LASIX (View Lasix Review and Lasix Label ).

6643046-5 | Cardiac Arrest, Extubation, Torsade De Pointes, Ventricular Arrhythmia
Patient was taking Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), extubation, torsade de pointes, ventricular arrhythmia on Mar 12, 2010 from FRANCE Additional patient health information: Female patient , weighting 198.4 lb, was diagnosed with influenza, anxiety (What is anxiety?) and. Zanamivir dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6621084-6 | Bradycardia
Adverse event was reported on Mar 03, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: ) was diagnosed with h1n1 influenza, acute respiratory distress syndrome and. Location: FRANCE , weighting 200.6 lb, Patient experienced the following unwanted or unexpected effects: bradycardia. During the same period patient was treated with OSELTAMIVIR PHOSPHATE (150mg Per Day) (View Oseltamivir Phosphate Review and Oseltamivir Phosphate Label ), ROCEPHIN (1g Per Day) (View Rocephin Review and Rocephin Label ), MIDAZOLAM HCL (20mgh Per Day) (View Midazolam Hcl Review and Midazolam Hcl Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), FENTANYL (.2mgh Per Day) (View Fentanyl Review and Fentanyl Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ), MECHANICAL VENTILATION (View Mechanical Ventilation Review and Mechanical Ventilation Label ).

6616029-9 |
on Feb 26, 2010 Female patient from FRANCE , weighting 35.27 lb, was diagnosed with h1n1 influenza, acute respiratory distress syndrome and was treated with Zanamivir (View Usage). . Zanamivir dosage: 20mgk Twice Per Day. During the same period patient was treated with VENTILATION (View Ventilation Review and Ventilation Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ), RIBAVIRIN (180mg Three Times Per Day) (View Ribavirin Review and Ribavirin Label ).

6610792-9 | Cytolytic Hepatitis
on Feb 22, 2010 Female patient from FRANCE , weighting 116.8 lb, was diagnosed with influenza, bronchospasm, sedation, nausea (What is nausea?) and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cytolytic hepatitis. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (20mg Three Times Per Day) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE (40mg Per Day) (View Esomeprazole Review and Esomeprazole Label ), TERBUTALINE SULFATE (5mg Three Times Per Day) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), LORAZEPAM (.5mg Three Times Per Day) (View Lorazepam Review and Lorazepam Label ), INSULINE (10iu Twice Per Day) (View Insuline Review and Insuline Label ), METOCLOPRAMIDE HYDROCHLORIDE (10mg Three Times Per Day) (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ).

6610781-4 | Aplasia, Pancytopenia, Transplant Failure
Patient was taking Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia, pancytopenia, transplant failure on Feb 26, 2010 from GERMANY Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with h1n1 influenza and. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with REBETOL (200mg Twice Per Day) (View Rebetol Review and Rebetol Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6602405-7 |
Adverse event was reported on Feb 16, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: 20mgk Twice Per Day) was diagnosed with h1n1 influenza, acute respiratory distress syndrome and. Location: FRANCE , weighting 35.27 lb, . During the same period patient was treated with VENTILATION (View Ventilation Review and Ventilation Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ), RIBAVIRIN (180mg Three Times Per Day) (View Ribavirin Review and Ribavirin Label ).

6600188-8 | Bradycardia
on Feb 16, 2010 Female patient from FRANCE , weighting 200.6 lb, was diagnosed with h1n1 influenza, bradycardia and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: bradycardia. Zanamivir dosage: . During the same period patient was treated with ATROPINE (View Atropine Review and Atropine Label ), ISUPREL (View Isuprel Review and Isuprel Label ), OSELTAMIVIR PHOSPHATE (150mg Per Day) (View Oseltamivir Phosphate Review and Oseltamivir Phosphate Label ), ROCEPHIN (1g Per Day) (View Rocephin Review and Rocephin Label ), MIDAZOLAM HCL (20mgh Per Day) (View Midazolam Hcl Review and Midazolam Hcl Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), FENTANYL 100 (.2mgh Per Day) (View Fentanyl-100 Review and Fentanyl-100 Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ).

6594373-1 | Blood Creatinine Increased, Blood Urea Increased, Haematotoxicity, Hepatic Enzyme Increased, Hepatic Function Abnormal, Hypotension, Hypoxia, Nervous System Disorder, Pneumothorax
on Feb 19, 2010 Male patient from UNITED STATES , 36 years of age, was diagnosed with h1n1 influenza and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, haematotoxicity, hepatic enzyme increased, hepatic function abnormal, hypotension, hypoxia, nervous system disorder, pneumothorax. Zanamivir dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6590417-1 | Abortion Complete, Vaginal Haemorrhage
Patient was taking Zanamivir (View Usage). Patient had the following side effects: abortion complete, vaginal haemorrhage on Feb 16, 2010 from THAILAND Additional patient health information: Female patient , 28 years of age, weighting 105.8 lb, was diagnosed with upper respiratory tract infection and. Zanamivir dosage: 2puff Per Day. During the same period patient was treated with AMOXICILLIN (500mg Three Times Per Day) (View Amoxicillin Review and Amoxicillin Label ), LORATADINE (10mg Per Day) (View Loratadine Review and Loratadine Label ), AMBROXOL (30mg Three Times Per Day) (View Ambroxol Review and Ambroxol Label ), ACETAMINOPHEN (500mg As Required) (View Acetaminophen Review and Acetaminophen Label ).

6588871-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Cholestasis, Gamma-glutamyltransferase Increased, Hepatocellular Injury, Renal Failure
Adverse event was reported on Feb 11, 2010 by a Male patient taking Zanamivir (View Usage) (Dosage: 600mg Single Dose) was diagnosed with h1n1 influenza, infection (What is infection?), sedation and. Location: FRANCE , weighting 110.2 lb, After Zanamivir was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, cholestasis, gamma-glutamyltransferase increased, hepatocellular injury, renal failure. During the same period patient was treated with CEFOTAXIME (3g Three Times Per Day) (View Cefotaxime Review and Cefotaxime Label ), CEFTRIAXONE SODIUM (2g Per Day) (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), MILRINONE (View Milrinone Review and Milrinone Label ), KETAMINE HCL (3mgkh Per Day) (View Ketamine Hcl Review and Ketamine Hcl Label ), MIDAZOLAM HCL (.2mgkh Per Day) (View Midazolam Hcl Review and Midazolam Hcl Label ), SUFENTA (.3mgkh Per Day) (View Sufenta Review and Sufenta Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ), NIMBEX (View Nimbex Review and Nimbex Label ).

6588838-6 | Blood Creatinine Increased, Haematotoxicity, Hepatic Enzyme Increased, Hepatic Function Abnormal, Hypotension, Hypoxia, Nervous System Disorder, Pupil Fixed
on Feb 12, 2010 Male patient from UNITED STATES , 36 years of age, was diagnosed with h1n1 influenza and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, haematotoxicity, hepatic enzyme increased, hepatic function abnormal, hypotension, hypoxia, nervous system disorder, pupil fixed. Zanamivir dosage: .

6578313-7 | Cytolytic Hepatitis
on Feb 05, 2010 Female patient from FRANCE , weighting 116.8 lb, was diagnosed with influenza, bronchospasm, sedation, nausea (What is nausea?) and was treated with Zanamivir (View Usage). Patient had the following side effects: cytolytic hepatitis. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (20mg Three Times Per Day) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE (40mg Per Day) (View Esomeprazole Review and Esomeprazole Label ), TERBUTALINE SULFATE (5mg Three Times Per Day) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), LORAZEPAM (.5mg Three Times Per Day) (View Lorazepam Review and Lorazepam Label ), INSULINE (10iu Twice Per Day) (View Insuline Review and Insuline Label ), METOCLOPRAMIDE (10mg Three Times Per Day) (View Metoclopramide Review and Metoclopramide Label ).

6578312-5 | Cardiac Arrest, Extubation, Torsade De Pointes, Ventricular Arrhythmia, Ventricular Fibrillation
Patient was taking Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), extubation, torsade de pointes, ventricular arrhythmia, ventricular fibrillation on Feb 04, 2010 from FRANCE Additional patient health information: Female patient , weighting 198.4 lb, was diagnosed with influenza, anxiety (What is anxiety?) and. Zanamivir dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6576912-X | Cardiotoxicity, Liver Disorder, Renal Failure
Adverse event was reported on Feb 01, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: ) was diagnosed with h1n1 influenza and. Location: GERMANY , weighting 50.71 lb, Patient experienced the following unwanted or unexpected effects: cardiotoxicity, liver disorder, renal failure. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HEPARIN (600ugk Per Day) (View Heparin Review and Heparin Label ), SODIUM NITROPRUSSIDE (View Sodium Nitroprusside Review and Sodium Nitroprusside Label ), SODIUM THIOSULPHATE (View Sodium Thiosulphate Review and Sodium Thiosulphate Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ). Patient was hospitalized.

6573770-4 | Cytolytic Hepatitis
on Feb 05, 2010 Male patient from FRANCE , weighting 205.0 lb, was diagnosed with influenza, pneumonia bacterial, asthma (What is asthma?) and was treated with Zanamivir (View Usage). Patient had the following side effects: cytolytic hepatitis. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with CEFTRIAXONE (1g Per Day) (View Ceftriaxone Review and Ceftriaxone Label ), SPIRAMYCIN (1.5iu6 Three Times Per Day) (View Spiramycin Review and Spiramycin Label ), TERBUTALINE SULFATE (5mg Four Times Per Day) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), METHYLPREDNISOLONE (80mg Per Day) (View Methylprednisolone Review and Methylprednisolone Label ).

6572189-X | Cytolytic Hepatitis, Pneumothorax
on Feb 02, 2010 Female patient from FRANCE , weighting 116.8 lb, was diagnosed with influenza, oedema, gastrooesophageal reflux disease, bronchospasm, sedation, hyperglycaemia, nausea (What is nausea?) and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cytolytic hepatitis, pneumothorax. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (20mg Three Times Per Day) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE (40mg Per Day) (View Esomeprazole Review and Esomeprazole Label ), TERBUTALINE SULFATE (5mg Three Times Per Day) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), LORAZEPAM (.5mg Three Times Per Day) (View Lorazepam Review and Lorazepam Label ), INSULINE (10iu Twice Per Day) (View Insuline Review and Insuline Label ), METOCLOPRAMIDE (10mg Three Times Per Day) (View Metoclopramide Review and Metoclopramide Label ).

6572169-4 | Pancytopenia
Patient was taking Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia on Jan 27, 2010 from GERMANY Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with h1n1 influenza, prophylaxis, bronchopulmonary aspergillosis and. Zanamivir dosage: . During the same period patient was treated with COTRIM (960mg Three Times Per Week) (View Cotrim Review and Cotrim Label ), VORICONAZOLE (200mg Twice Per Day) (View Voriconazole Review and Voriconazole Label ), CIPROFLAXACIN (400mg Three Times Per Day) (View Ciproflaxacin Review and Ciproflaxacin Label ).

6572163-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Cholestasis, Gamma-glutamyltransferase Increased, Hepatocellular Injury, Renal Failure
Adverse event was reported on Dec 07, 2009 by a Male patient taking Zanamivir (View Usage) (Dosage: ) was diagnosed with h1n1 influenza and. Location: FRANCE , weighting 110.2 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, cholestasis, gamma-glutamyltransferase increased, hepatocellular injury, renal failure. During the same period patient was treated with NIMBEX (View Nimbex Review and Nimbex Label ), LASILIX (100mg Per Day) (View Lasilix Review and Lasilix Label ), KETAMINE HCL (3mgkh Per Day) (View Ketamine Hcl Review and Ketamine Hcl Label ), HYPNOVEL (.2mgkh Per Day) (View Hypnovel Review and Hypnovel Label ), SUFENTA (.3mgkh Per Day) (View Sufenta Review and Sufenta Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), CLAFORAN (3g Three Times Per Day) (View Claforan Review and Claforan Label ).

6570678-5 | Ileus Paralytic
on Jan 11, 2010 Male patient from UNITED STATES , 53 years of age, weighting 240.3 lb, was diagnosed with h1n1 influenza, respiratory failure and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: ileus paralytic. Zanamivir dosage: 400mg Twice Per Day. During the same period patient was treated with BIPAP (View Bipap Review and Bipap Label ), TAMIFLU (150mg Twice Per Day) (View Tamiflu Review and Tamiflu Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6565120-4 | Ileus Paralytic
on Jan 11, 2010 Male patient from UNITED STATES , 53 years of age, was diagnosed with h1n1 influenza and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: ileus paralytic. Zanamivir dosage: 400mg Twice Per Day. During the same period patient was treated with BIPAP (View Bipap Review and Bipap Label ).

6556400-7 | Haemorrhage
Patient was taking Zanamivir (View Usage). Patient had the following side effects: haemorrhage on Jan 26, 2010 from UNITED STATES Additional patient health information: Female patient , 18 years of age, weighting 126.1 lb, was diagnosed with h1n1 influenza and. Zanamivir dosage: . During the same period patient was treated with INTUBATION (View Intubation Review and Intubation Label ).

6550533-7 | Bradycardia, Haemodynamic Instability
Adverse event was reported on Jan 20, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: ) was diagnosed with h1n1 influenza and. Location: FRANCE , weighting 141.1 lb, After Zanamivir was administered, patient had the following side effects: bradycardia, haemodynamic instability. During the same period patient was treated with OSELTAMIVIR (150mg Per Day) (View Oseltamivir Review and Oseltamivir Label ), ROCEPHIN (1g Per Day) (View Rocephin Review and Rocephin Label ), MIDAZOLAM HCL (20mgh Per Day) (View Midazolam Hcl Review and Midazolam Hcl Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), FENTANYL (.2mgh Per Day) (View Fentanyl Review and Fentanyl Label ).

6547008-8 | Pancytopenia
on Jan 21, 2010 Female patient from GERMANY , weighting 154.3 lb, was diagnosed with h1n1 influenza, prophylaxis, bronchopulmonary aspergillosis and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Zanamivir dosage: . During the same period patient was treated with COTRIM (960mg Three Times Per Week) (View Cotrim Review and Cotrim Label ), VORICONAZOLE (200mg Twice Per Day) (View Voriconazole Review and Voriconazole Label ), CIPROFLOXACIN (400mg Three Times Per Day) (View Ciprofloxacin Review and Ciprofloxacin Label ).

6547007-6 | Multi-organ Failure
on Jan 15, 2010 Female patient from FRANCE , weighting 242.5 lb, was diagnosed with h1n1 influenza and was treated with Zanamivir (View Usage). Patient had the following side effects: multi-organ failure. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with ULTIVA (View Ultiva Review and Ultiva Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), CORDARONE (View Cordarone Review and Cordarone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), INIPOMP (View Inipomp Review and Inipomp Label ), OSELTAMIVIR (150mg Twice Per Day) (View Oseltamivir Review and Oseltamivir Label ).

6543535-8 | Cytolytic Hepatitis
Patient was taking Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: cytolytic hepatitis on Jan 13, 2010 from FRANCE Additional patient health information: Male patient , weighting 208.1 lb, was diagnosed with influenza and. Zanamivir dosage: .

6543534-6 | Cytolytic Hepatitis
Adverse event was reported on Jan 13, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: 600mg Twice Per Day) was diagnosed with influenza, pneumonia (What is pneumonia?), sedation, paralysis (What is paralysis?), thrombosis prophylaxis, constipation (What is constipation?) and. Location: FRANCE , weighting 142.2 lb, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. During the same period patient was treated with CEFTRIAXONE (1g Per Day) (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CISATRACURIUM BESYLATE (View Cisatracurium Besylate Review and Cisatracurium Besylate Label ), ENOXAPARIN SODIUM (4000iu Per Day) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), MACROGOL (2 Per Day) (View Macrogol Review and Macrogol Label ).

6542244-9 | Pancytopenia
on Jan 14, 2010 Female patient from GERMANY , weighting 154.3 lb, was diagnosed with h1n1 influenza, prophylaxis, bronchopulmonary aspergillosis and was treated with Zanamivir (View Usage). Patient had the following side effects: pancytopenia. Zanamivir dosage: . During the same period patient was treated with COTRIM (960mg Three Times Per Week) (View Cotrim Review and Cotrim Label ), VORICONAZOLE (200mg Twice Per Day) (View Voriconazole Review and Voriconazole Label ), CIPROFLOXACIN (400mg Three Times Per Day) (View Ciprofloxacin Review and Ciprofloxacin Label ).

6542224-3 | Agitation, Anuria, Anxiety, Ascites, Cardiogenic Shock, Circulatory Collapse, Gastrointestinal Haemorrhage, Haemodynamic Instability, Haemorrhagic Stroke
on Jan 08, 2010 Female patient from FRANCE , weighting 156.5 lb, was diagnosed with h1n1 influenza, myocarditis, respiratory distress and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: agitation, anuria, anxiety (What is anxiety?), ascites, cardiogenic shock, circulatory collapse, gastrointestinal haemorrhage, haemodynamic instability, haemorrhagic stroke. Zanamivir dosage: 250mg Twice Per Day. During the same period patient was treated with TAREG (40mg Per Day) (View Tareg Review and Tareg Label ), TAMIFLU (150mg Twice Per Day) (View Tamiflu Review and Tamiflu Label ), CORTICOID (1mgk Per Day) (View Corticoid Review and Corticoid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), LASILIX (View Lasilix Review and Lasilix Label ).

6541204-1 | Cytolytic Hepatitis
Patient was taking Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis on Jan 15, 2010 from FRANCE Additional patient health information: Female patient , weighting 116.8 lb, was diagnosed with influenza, bronchospasm, sedation, nausea (What is nausea?) and. Zanamivir dosage: 600mg Twice Per Day. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (20mg Three Times Per Day) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE (40mg Per Day) (View Esomeprazole Review and Esomeprazole Label ), TERBUTALINE SULFATE (5mg Three Times Per Day) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), LORAZEPAM (.5mg Three Times Per Day) (View Lorazepam Review and Lorazepam Label ), INSULINE (10iu Twice Per Day) (View Insuline Review and Insuline Label ), METOCLOPRAMIDE (10mg Three Times Per Day) (View Metoclopramide Review and Metoclopramide Label ).

6541156-4 |
Adverse event was reported on Jan 11, 2010 by a Female patient taking Zanamivir (View Usage) (Dosage: 600mg Twice Per Day) was diagnosed with h1n1 influenza and. Location: UNITED STATES , 18 years of age, . During the same period patient was treated with INTUBATION (View Intubation Review and Intubation Label ).

6539573-1 | Arrhythmia, Cardiac Arrest, Extubation, Torsade De Pointes, Ventricular Fibrillation
on Jan 07, 2010 Female patient from FRANCE , weighting 198.4 lb, was diagnosed with influenza, anxiety (What is anxiety?) and was treated with Zanamivir (View Usage). After Zanamivir was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), cardiac arrest (What is cardiac arrest?), extubation, torsade de pointes, ventricular fibrillation. Zanamivir dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ). Patient was hospitalized.

6539557-3 | Acute Respiratory Distress Syndrome, Cardio-respiratory Arrest
on Jan 15, 2010 Male patient from FRANCE , weighting 220.5 lb, was diagnosed with influenza, acute respiratory distress syndrome and was treated with Zanamivir (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, cardio-respiratory arrest. Zanamivir dosage: 600mg Variable Dose. During the same period patient was treated with INTUBATION (View Intubation Review and Intubation Label ).

6537672-1 | Cytolytic Hepatitis
Patient was taking Zanamivir (View Usage). Patient had the following side effects: cytolytic hepatitis on Jan 06, 2010 from FRANCE Additional patient health information: Male patient , weighting 208.1 lb, was diagnosed with influenza and. Zanamivir dosage: .